NEVO, the Sirolimus Eluting stent: first clinical results and future developments of RES Technology
CCVI @ EuroPCR programme highlight NEVO, the Sirolimus Eluting stent: first clinical results and future developments of RES Technology
Wednesday 20th May, 17.00 – 18.30, Main Arena
Chairman: Patrick Serruys
Chairman: Patrick Serruys
Educational goals:
- Present the latest outcomes of pre-clinical trials and first results from the NEVO I Trial
- Make delegates aware of the forthcoming innovations in RES Technolog
- Introduction of the efficacy and safety of CYPHER (ARTS II results)
Programme
- Pre-clinical results of the NEVO stent - Elzar Edelman
- First results from NEVO RES I Trial: Six month follow-up - Christian Spaulding
- NEVO RES I Trial: First report of IVUS sub-study results - Peter Fitzgerald
- The current and future clinical programmes of NEVO Trials - William Wijns
- Future innovations utilizing RES Technology - Bob Falotico
